MedPath

Trans-dermal Fentanyl patch compared to intravenous morphine, efficacy on post thoracotomy pai

Not Applicable
Conditions
Postoperative thoracic surgery pain management.
Postprocedural respiratory disorder, unspecified
Registration Number
IRCT201203067752N2
Lead Sponsor
Vice-chancellor of research of Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with ASA class I and II; who were candidates forelective thoracic surgery.
Exclusion criteria History of allergies or hypersensitivity to opioid; addiction to alcohol or narcotics; dementia; psychological disorders; skin diseases that preventing the absorption oftransdermal fentanil patch ; pregnant or breast-feeding mothers; the patients undergoing intra pleural or intercostals blockage.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative paine. Timepoint: 72 hours postoperative. Method of measurement: Visual Analog Scale.;The amount of Morphine. Timepoint: 72 hours postoperative. Method of measurement: miligram.
Secondary Outcome Measures
NameTimeMethod
Systolic Blood Pressure. Timepoint: 72 h postoperative. Method of measurement: mm/Hg.;Diaystolic Blood Pressure. Timepoint: 72 h postoperative. Method of measurement: mm/Hg.;?Respiratory depression. Timepoint: 72 h postoperative. Method of measurement: Respiratory rate for min.;Heart Rate. Timepoint: 72 h postoperative. Method of measurement: Heart Rate for 1 min.
© Copyright 2025. All Rights Reserved by MedPath